PHASE II TRIAL OF GVHD PROPHYLAXIS WITH POST-TRANSPLANTATION CYCLOPHOSPHAMIDE FOLLOWING REDUCED-INTENSITY BUSULFAN/FLUDARABINE (BU/FLU) CONDITIONING FOR HEMATOLOGICAL MALIGNANCIES

GVHD-prophylaxis with post-transplant cyclophosphamide (CY) following ablative HLA-matched bone marrow (BM) transplantation has been reported to have comparable rates of acute GVHD with an apparent reduction in chronic GVHD and infections. We conducted a phase II trial of post-CY following reduced-i...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biol Blood Marrow Transplant
Autori principali: Alousi, Amin M., Brammer, Jonathan E., Saliba, Rima M., Andersson, Borje, Popat, Uday, Hosing, Chitra, Jones, Roy, Shpall, Elizabeth J, Khouri, Issa, Qazilbash, Muzaffar, Nieto, Yago, Shah, Nina, Ahmed, Sairah, Oran, Betul, Atrash, Gheath Al, Ciurea, Stefan, Kebriaei, Partow, Chen, Julianne, Rondon, Gabriela, Champlin, Richard
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4825327/
https://ncbi.nlm.nih.gov/pubmed/25667989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.01.026
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi